Signify Premium Insight: Tempus’ Arterys Acquisition and AI’s Turning Tide

Medical imaging AI vendor Arterys recently announced it has been acquired by Tempus Labs (Tempus), in a move that ranks among the largest acquisitions of an AI vendor to date. The move continues AI’s march beyond its radiology bastion, with Tempus, backed by $1.3bn in VC funding, among the leaders in the precision medicine and treatment discovery segment.

The price Tempus has paid for Arterys – a vendor which has raised more than $70m in funding – or the exact nature of its plans for the company, have not been disclosed, although it is likely that Arterys will continue to offer its core radiology products, alongside supporting Tempus’ other operations in the preclinical and life science sectors.